Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 10/20 | 0.36 |
| ▸ | RXRA | P19793 | 10/20 | 0.36 |
| ▸ | RARA | P10276 | 8/20 | 0.36 |
| ▸ | RXRB | P28702 | 6/20 | 0.36 |
| ▸ | RXRG | P48443 | 5/20 | 0.36 |
| ▸ | RARG | P13631 | 7/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17911672 | 1.00 | RARB (0.36) | RARBRXRARARARXRBRXRG | |
| SCHEMBL30062693 | 0.76 | RXRA (0.38) | RARBRXRARARARXRBRXRG | |
| SCHEMBL8158082 | 0.72 | RARB (0.40) | RARBRXRARARARXRBRXRG | |
| SCHEMBL9985162 | 0.66 | HTR7 (0.40) | RARBRXRARARARXRBRXRG | |
| SCHEMBL4970470 | 0.66 | RXRA (0.31) | RARBRXRARARARXRBRXRG | |
| SCHEMBL23443220 | 0.62 | CYP26A1 (0.35) | RARBRXRARARARXRBRARG | |
| Hydrochloric Acid SCHEMBL2237819 | 0.62 | RXRA (0.38) | RARBRXRARARARXRBRXRG | |
| SCHEMBL29401105 | 0.62 | RXRA (0.41) | RARBRXRARARARXRBRXRG | |
| SCHEMBL5009416 | 0.62 | RXRA (0.41) | RARBRXRARARARXRBRXRG | |
| SCHEMBL6909595 | 0.61 | RXRA (0.61) | RARBRXRARARARXRBRXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12529167-B2 | Bicomponent polymeric fibers | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2026-01-20 | — | — | US | disclosed |
| US-20230332335-A1 | Bicomponent Polymeric Fibers | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-10-19 | — | — | US | disclosed |
| US-11549201-B2 | Fibers and nonwoven materials prepared therefrom | EXXONMOBIL CHEMICALS PATENTS INC. (US) | 2023-01-10 | — | — | US | disclosed |
| US-11525041-B2 | Process for producing polymers | EXXONMOBIL CHEMICALS PATENTS INC. (US) | 2022-12-13 | — | — | US | disclosed |
| US-11492477-B2 | Polymer compositions and nonwoven compositions prepared therefrom | EXXONMOBIL CHEMICALS PATENT INC. (US) | 2022-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12529167-B2 | Bicomponent polymeric fibers | MST1, COPE, MSTN | RARB 4571/4885RXRA 3480/4885RARA 4576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.